How have XCRT shares performed in 2024?

Xcelerate's stock was trading at $0.0360 at the beginning of the year. Since then, XCRT shares have decreased by 2.4% and is now trading at $0.0352. View the best growth stocks for 2024 here .

How do I buy shares of Xcelerate?

Shares of XCRT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:XCRT

Xcelerate (XCRT) Stock Price, News & Analysis

→ Biden replacement revealed? (From Paradigm Press) (Ad)

Free XCRT Stock Alerts

$0.04

0.00 (0.00%)

(As of 04/15/2024 ET)

Compare

Today's Range: $0.03
▼
$0.04
50-Day Range: $0.03
▼
$0.05
52-Week Range: $0.03
▼
$0.14

Volume: 33,409 shs
Average Volume: 141,920 shs
Market Capitalization: $15.27 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Financials SEC Filings Short Interest

Get Xcelerate alerts:

Ad Priority Gold

Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!

Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.

Click here for your free guide

About Xcelerate Stock (OTCMKTS:XCRT)

Xcelerate Inc. acquires engineering/patents and applies to early-stage medical technology companies. The company engages in the formulation, packaging and marketing of consumer health and beauty, and clinically tested skin care products; development of artificial intelligence and virtual health technology to assist patients; owning and licensing the rights to various forms of medical equipment. It also provides Ceramedx, a natural plant based therapeutic skin care product; Earth Science Beauty, which offers natural facial skincare targeted to specific skin types. The company was formerly known as Union Dental Holdings, Inc. and changed its name to Xcelerate Inc. Xcelerate Inc. was incorporated in 1996 is based in Mauldin, South Carolina.

XCRT Stock Price History

30 days | 90 days | 365 days | Advanced Chart

XCRT Stock News Headlines

January 19, 2024 | finance.yahoo.com

Xcelerate, Inc. Announces Participation in The Microcap Conference

October 24, 2023 | finance.yahoo.com

Xcelerate, Inc. Announces Publication of its Two Utility Patent Applications

April 16, 2024 | Crypto Swap Profits (Ad)

Did You Get Your Free Bitcoin Yet?

And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.

September 14, 2023 | stockhouse.com

Xcelerate, Inc. Announces that ESN Group, Inc. Has Been Approved as a Vendor to Army & Air Force Exchange Service

September 14, 2023 | finance.yahoo.com

Xcelerate, Inc. Announces that ESN Group, Inc. Has Been Approved as a Vendor to Army & Air Force Exchange Service

August 8, 2023 | finanznachrichten.de

Xcelerate, Inc.: Xcelerate Announces Marketing Agreement

August 8, 2023 | finance.yahoo.com

Xcelerate Announces Marketing Agreement

July 25, 2023 | finance.yahoo.com

Xcelerate, Inc. Acquires a Majority Interest in ESN Group

April 16, 2024 | Crypto Swap Profits (Ad)

Did You Get Your Free Bitcoin Yet?

April 20, 2023 | finance.yahoo.com

Xcelerate, Inc. Announces PTO and PCT Filings For Surgical Devices

April 12, 2023 | finance.yahoo.com

Xcelerate, Inc. Announces Agreement to Acquire a Controlling Interest in ESN, Inc.

March 14, 2023 | finanznachrichten.de

Xcelerate, Inc.: Xcelerate Announces that Afya Sasa Signs Agreement with the National Hospital of Tanzania

March 14, 2023 | finance.yahoo.com

Xcelerate Announces that Afya Sasa Signs Agreement with the National Hospital of Tanzania

February 1, 2023 | finance.yahoo.com

Fabian Urquijo Joins the Advisory Board of Xcelerate, Inc.

January 17, 2023 | finanznachrichten.de

Xcelerate, Inc.: Xcelerate Inc. to Acquire Controlling Interest in ESN Group, Inc

January 17, 2023 | seekingalpha.com

Xcelerate to acquire controlling interest in ESN Group

January 17, 2023 | finance.yahoo.com

Xcelerate Inc. to Acquire Controlling Interest in ESN Group, Inc

January 3, 2023 | finance.yahoo.com

Xcelerate, Inc. Releases Message from CEO

August 31, 2022 | proactiveinvestors.com

Xcelerate Inc: Spanning divide between engineering advancements and application to clinical care

August 30, 2022 | finance.yahoo.com

Xcelerate, Inc. to Develop Consumer Healthcare Products

August 24, 2022 | finanznachrichten.de

Xcelerate, Inc.: Additional Countries Add Patent Protection

August 23, 2022 | finance.yahoo.com

Additional Countries Add Patent Protection

August 16, 2022 | finance.yahoo.com

Xcelerate Inc. (XCRT)

August 3, 2022 | yahoo.com

Love Island’s Luca Bish slammed again for ‘over-reacting’

August 2, 2022 | yahoo.com

Delaware masking guidance changes as all three counties have 'high' spread of COVID

August 2, 2022 | yahoo.com

Loyal man charged with hit-and-run

August 1, 2022 | finance.yahoo.com

Xcelerate, Inc. Announces Uplisting to OTCQB Market

See More Headlines

Receive XCRT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Xcelerate and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today: 4/16/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Health services
Sub-Industry: N/A
Current Symbol: OTCMKTS:XCRT
CUSIP: N/A
CIK: 1138586
Web: newudhi.com
Phone: (854) 900-2020
Fax: N/A
Employees: 24
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: 434,450,000
Free Float: N/A
Market Cap: $15.27 million
Optionable: Not Optionable
Beta: 2.74

Elon Musk's Next Move

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Key Executives

Dr. George D. Green (Age 64)
CFO & Secretary
Comp: $114k
Mr. Michael F. O'Shea (Age 73)
President, CEO & Chairman
Dr. Anja Glisovic-Rosch (Age 46)
Interim Chief Science Officer

Key Competitors

View All Competitors

XCRT Stock Analysis - Frequently Asked Questions

How have XCRT shares performed in 2024?: Xcelerate's stock was trading at $0.0360 at the beginning of the year. Since then, XCRT shares have decreased by 2.4% and is now trading at $0.0352.
View the best growth stocks for 2024 here.
How do I buy shares of Xcelerate?: Shares of XCRT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:XCRT) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial